Flt-1 haploinsufficiency ameliorates muscular dystrophy phenotype by developmentally increased vasculature in mdx mice

Human Molecular Genetics

Volumn 19, Issue 21, 2010, Pages 4145-4159

  Verma, Mayank ^a   Asakura, Yoko ^a   Hirai, Hiroyuki ^a   Watanabe, Shuichi ^a   Tastad, Christopher ^a   Fong, Guo Hua ^b   Ema, Masatsugu ^c   Call, Jarrod A ^a   Lowe, Dawn A ^a   Asakura, Atsushi ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; UTROPHIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; CALCIFICATION; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; EMBRYO DEVELOPMENT; FIBROSIS; FLUORESCENCE ACTIVATED CELL SORTING; HETEROZYGOSITY; HISTOLOGY; HOMOZYGOSITY; LASER DOPPLER FLOWMETRY; MOUSE; MUSCLE BLOOD FLOW; MUSCLE CELL; MUSCLE CONTRACTILITY; MUSCLE FORCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKELETAL MUSCLE; STEM CELL; SURVIVAL RATE; WESTERN BLOTTING;

ANIMALS; CELL PROLIFERATION; HAPLOINSUFFICIENCY; HETEROZYGOTE; HOMOZYGOTE; MICE; MICE, INBRED MDX; MICE, KNOCKOUT; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; PHENOTYPE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

ANIMALIA; MUS;

EID: 77957875129     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq334     Document Type: Article

References (60)

1. Dalkilic, I. and Kunkel, L.M. (2003) Muscular dystrophies: genes to pathogenesis. Curr. Opin. Genet. Dev., 13, 231-238.
2. Davies, K.E. and Nowak, K.J. (2006) Molecular mechanisms of muscular dystrophies: old and new players. Nat. Rev. Mol. Cell Biol., 7, 762-773.
3. Mendell, J.R., Engel, W.K. and Derrer, E.C. (1971) Duchenne muscular dystrophy: functional ischemia reproduces its characteristic lesions. Science, 172, 1143-1145.
4. Miyatake, M., Miike, T., Zhao, J., Yoshioka, K., Uchino, M. and Usuku, G. (1989) Possible systemic smooth muscle layer dysfunction due to a deficiency of dystrophin in duchenne muscular dystrophy. J. Neurol. Sci., 93, 11-17.
5. Ito, K., Kimura, S., Ozasa, S., Matsukura, M., Ikezawa, M., Yoshioka, K., Ueno, H., Suzuki, M., Araki, K., Yamamura, K. et al. (2006) Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice. Hum. Mol. Genet., 15, 2266-2275.
6. Cullen, M.J. and Jaros, E. (1988) Ultrastructure of the skeletal muscle in the X chromosome-linked dystrophic (mdx) mouse: comparison with duchenne muscular dystrophy. Acta Neuropathol., 77, 69-81.
7. Loufrani, L., Levy, B.I. and Henrion, D. (2002) Defect in microvascular adaptation to chronic changes in blood flow in mice lacking the gene encoding for dystrophin. Circ. Res., 91, 1183-1189.
8. Loufrani, L., Matrougui, K., Gorny, D., Duriez, M., Blanc, I., Levy, B.I. and Henrion, D. (2001) Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin. Circulation, 103, 864-870.
9. Weir, A.P., Burton, E.A., Harrod, G. and Davies, K.E. (2002) A-and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle. J. Biol. Chem., 277, 45285-45290.
10. Coral-Vazquez, R., Cohn, R.D., Moore, S.A., Hill, J.A., Weiss, R.M., Davisson, R.L., Straub, V., Barresi, R., Bansal, D., Hrstka, R.F. et al. (1999) Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell, 98, 465-474.
11. Rando, T.A. (2001) Role of nitric oxide in the pathogenesis of muscular dystrophies: a 'two hit' hypothesis of the cause of muscle necrosis. Microsc. Res. Tech., 55, 223-235.
12. Asai, A., Sahani, N., Kaneki, M., Ouchi, Y., Martyn, J.A. and Yasuhara, S.E. (2007) Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy. PLoS ONE, 2, e806.
13. Fong, G.H., Rossant, J., Gertsenstein, M. and Breitman, M.L. (1995) Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature, 376, 66-70.
14. Fong, G.H., Zhang, L., Bryce, D.M. and Peng, J. (1999) Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Development, 126, 3015-3025.
15. Ferrara, N., Gerber, H.P. and LeCouter, J. (2003) The biology of VEGF and its receptors. Nat. Med., 9, 669-676.
16. Kearney, J.B., Ambler, C.A., Monaco, K.A., Johnson, N., Rapoport, R.G. and Bautch, V.L. (2002) Vascular endothelial growth factor receptor flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division. Blood, 99, 2397-2407.
17. Springer, M.L., Ozawa, C.R., Banfi, A., Kraft, P.E., Ip, T.K., Brazelton, T.R. and Blau, H.M. (2003) Localized arteriole formation directly adjacent to the site of VEGF-induced angiogenesis in muscle. Mol. Ther., 7, 441-449.
18. Arsic, N., Zacchigna, S., Zentilin, L., Ramirez-Correa, G., Pattarini, L., Salvi, A., Sinagra, G. and Giacca, M. (2004) Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo. Mol. Ther., 10, 844-854.
19. Messina, S., Mazzeo, A., Bitto, A., Aguennouz, M., Migliorato, A., De Pasquale, M.G., Minutoli, L., Altavilla, D., Zentilin, L., Giacca, M. et al. (2007) VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice. FASEB J., 21, 3737-3746.
20. Coulton, G.R., Curtin, N.A., Morgan, J.E. and Partridge, T.A. (1988) The mdx mouse skeletal muscle myopathy. II. Contractile properties. Neuropathol. Appl. Neurobiol., 14, 299-314.
21. Coulton, G.R., Morgan, J.E., Partridge, T.A. and Sloper, J.C. (1988) The mdx mouse skeletal muscle myopathy. I. A histological, morphometric and biochemical investigation. Neuropathol. Appl. Neurobiol., 14, 53-70.
22. Danko, I., Chapman, V. and Wolff, J.A. (1992) The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy. Pediatr. Res., 32, 128-131.
23. Deconinck, A.E., Rafael, J.A., Skinner, J.A., Brown, S.C., Potter, A.C., Metzinger, L., Watt, D.J., Dickson, J.G., Tinsley, J.M. and Davies, K.E. (1997) Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell, 90, 717-727.
24. Matsuda, R., Nishikawa, A. and Tanaka, H. (1995) Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J. Biochem. (Tokyo), 118, 959-964.
25. Hamer, P.W., McGeachie, J.M., Davies, M.J. and Grounds, M.D. (2002) Evans blue dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability. J. Anat., 200, 69-79.
26. Suelves, M., Vidal, B., Serrano, A.L., Tjwa, M., Roma, J., Lopez-Alemany, R., Luttun, A., de Lagran, M.M., Diaz-Ramos, A., Jardi, M. et al. (2007) uPA deficiency exacerbates muscular dystrophy in MDX mice. J. Cell Biol., 178, 1039-1051.
27. Pastoret, C. and Sebille, A. (1995) Mdx mice show progressive weakness and muscle deterioration with age. J. Neurol. Sci., 129, 97-105.
28. Brack, A.S., Bildsoe, H. and Hughes, S.M. (2005) Evidence that satellite cell decrement contributes to preferential decline in nuclear number from large fibres during murine age-related muscle atrophy. J. Cell. Sci., 118, 4813-4821.
29. Maggs, A.M., Taylor-Harris, P., Peckham, M. and Hughes, S.M. (2000) Evidence for differential post-translational modifications of slow myosin heavy chain during murine skeletal muscle development. J. Muscle Res. Cell. Motil., 21, 101-113.
30. Grady, R.M., Teng, H., Nichol, M.C., Cunningham, J.C., Wilkinson, R.S. and Sanes, J.R. (1997) Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell, 90, 729-738.
31. Sawano, A., Iwai, S., Sakurai, Y., Ito, M., Shitara, K., Nakahata, T. and Shibuya, M. (2001) Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood, 97, 785-791.
32. Ema, M., Takahashi, S. and Rossant, J. (2006) Deletion of the selection cassette, but not cis-acting elements, in targeted Flk1-lacZ allele reveals Flk1 expression in multipotent mesodermal progenitors. Blood, 107, 111-117.
33. Tajbakhsh, S., Rocancourt, D. and Buckingham, M. (1996) Muscle progenitor cells failing to respond to positional cues adopt non-myogenic fates in myf-5 null mice. Nature, 384, 266-270.
34. Beauchamp, J.R., Heslop, L., Yu, D.S., Tajbakhsh, S., Kelly, R.G., Wernig, A., Buckingham, M.E., Partridge, T.A. and Zammit, P.S. (2000) Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J. Cell Biol., 151, 1221-1234.
35. Shefer, G. and Yablonka-Reuveni, Z. (2005) Isolation and culture of skeletal muscle myofibers as a means to analyze satellite cells. Methods Mol. Biol., 290, 281-304.
36. Fukada, S., Higuchi, S., Segawa, M., Koda, K., Yamamoto, Y., Tsujikawa, K., Kohama, Y., Uezumi, A., Imamura, M., Miyagoe-Suzuki, Y. et al. (2004) Purification and cell-surface marker characterization of quiescent satellite cells from murine skeletal muscle by a novel monoclonal antibody. Exp. Cell Res., 296, 245-255.
37. Cossu, G. and Sampaolesi, M. (2007) New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials. Trends Mol. Med., 13, 520-526.
38. O'Brien, K.F. and Kunkel, L.M. (2001) Dystrophin and muscular dystrophy: past, present, and future. Mol. Genet. Metab., 74, 75-88.
39. Sato, K., Yokota, T., Ichioka, S., Shibata, M. and Takeda, S. (2008) Vasodilation of intramuscular arterioles under shear stress in dystrophin-deficient skeletal muscle is impaired through decreased nNOS expression. Acta Myol., 27, 30-36.
40. Wehling, M., Spencer, M.J. and Tidball, J.G. (2001) A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J. Cell Biol., 155, 123-131.
41. Wehling-Henricks, M., Lee, J.J. and Tidball, J.G. (2004) Prednisolone decreases cellular adhesion molecules required for inflammatory cell infiltration in dystrophin-deficient skeletal muscle. Neuromuscul. Disord., 14, 483-490.
42. Barleon, B., Sozzani, S., Zhou, D., Weich, H.A., Mantovani, A. and Marme, D. (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood, 87, 3336-3343.
43. Deasy, B.M., Feduska, J.M., Payne, T.R., Li, Y., Ambrosio, F. and Huard, J. (2009) Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle. Mol. Ther., 17, 1788-1798.
44. Dawson, D., Vincent, M.A., Barrett, E.J., Kaul, S., Clark, A., Leong-Poi, H. and Lindner, J.R. (2002) Vascular recruitment in skeletal muscle during exercise and hyperinsulinemia assessed by contrast ultrasound. Am. J. Physiol. Endocrinol. Metab., 282, E714-E720.
45. Lindbom, L. (1983) Microvascular blood flow distribution in skeletal muscle. An intravital microscopic study in the rabbit. Acta Physiol. Scand. Suppl., 525, 1-40.
46. Crosbie, R.H. (2001) NO vascular control in Duchenne muscular dystrophy. Nat. Med., 7, 27-29.
47. Christov, C., Chretien, F., Abou-Khalil, R., Bassez, G., Vallet, G., Authier, F.J., Bassaglia, Y., Shinin, V., Tajbakhsh, S., Chazaud, B. et al. (2007) Muscle satellite cells and endothelial cells: close neighbors and privileged partners. Mol. Biol. Cell, 18, 1397-1409.
48. Germani, A., Di Carlo, A., Mangoni, A., Straino, S., Giacinti, C., Turrini, P., Biglioli, P. and Capogrossi,M.C. (2003) Vascular endothelial growth factor modulates skeletal myoblast function. Am. J. Pathol., 163, 1417-1428.
49. Yan, H., Guo, Y., Zhang, P., Zu, L., Dong, X., Chen, L., Tian, J., Fan, X., Wang, N., Wu, X. et al. (2005) Superior neovascularization and muscle regeneration in ischemic skeletal muscles following VEGF gene transfer by rAAV1 pseudotyped vectors. Biochem. Biophys. Res. Commun., 336, 287-298.
50. Borselli, C., Storrie, H., Benesch-Lee, F., Shvartsman, D., Cezar, C., Lichtman, J.W., Vandenburgh, H.H. and Mooney, D.J. (2005) Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc. Natl Acad. Sci. USA, 107, 3287-3292.
51. Asakura, A., Lyons, G.E. and Tapscott, S.J. (1995) The regulation of MyoD gene expression: conserved elements mediate expression in embryonic axial muscle. Dev. Biol., 171, 386-398.
52. Abramoff, M.D., Magelhaes, P.J. and Ram, S.J. (2004) Image processing with ImageJ. Biophotonics Int., 11, 36-42.
53. Baltgalvis, K.A., Call, J.A., Nikas, J.B. and Lowe, D.A. (2009) Effects of prednisolone on skeletal muscle contractility in mdx mice. Muscle Nerve, 40, 443-454.
54. Sonnemann, K.J., Fitzsimons, D.P., Patel, J.R., Liu, Y., Schneider, M.F., Moss, R.L. and Ervasti, J.M. (2006) Cytoplasmic gamma-actin is not required for skeletal muscle development but its absence leads to a progressive myopathy. Dev. Cell., 11, 387-397.
55. Clark, A.D., Youd, J.M., Rattigan, S., Barrett, E.J. and Clark, M.G. (2001) Heterogeneity of laser Doppler flowmetry in perfused muscle indicative of nutritive and nonnutritive flow. Am. J. Physiol. Heart Circ. Physiol., 280, H1324-H1333.
56. Asakura, A., Komaki, M. and Rudnicki, M. (2001) Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation, 68, 245-253.
57. Asakura, A. and Rudnicki, M.A. (2002) Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation. Exp. Hematol., 30, 1339-1345.
58. Asakura, A., Hirai, H., Kablar, B., Morita, S., Ishibashi, J., Piras, B.A., Christ, A.J., Verma, M., Vineretsky, K.A. and Rudnicki, M.A. (2007) Increased survival of muscle stem cells lacking the MyoD gene after transplantation into regenerating skeletal muscle. Proc. Natl Acad. Sci. USA, 104, 16552-16557.
59. -/- myogenic cells derived from adult skeletal muscle. J. Cell Biol., 144, 631-643.
60. Thompson, L.V., Durand, D., Fugere, N.A. and Ferrington, D.A. (2006) Myosin and actin expression and oxidation in aging muscle. J. Appl. Physiol., 101, 1581-1587.